Clinical Trial

Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 9, 2024 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Axial Spondyloarthritis
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06197009
Lead Sponsor Sinocelltech Ltd.
Conditions Axial Spondyloarthritis
Enrollment 168 participants
Start Date 2024-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-01-09